Tweet
AFP
<img alt="" height="1" width="1" />
Glaxo eyes token profit on malaria vaccine
Reuters
NEW YORK, Jan 20 (Reuters) - GlaxoSmithKline Plc (GSK.L) hopes to seek approval by 2012 for its experimental vaccine to prevent malaria and will seek only a small profit on the product in order to make it widely available in ...
GSK Offers Scientists Labs, Data to Fight MalariaABC News
GSK releases chemicals to help find malaria cure: reportAFP
How GlaxoSmithKline chief has changed the agenda for big pharmaThe Guardian
Times Online -Gaea Times (blog)
all 86 news articles »
More...